We wanted to let you know some important information about Wellcare’s PDP products in 2025.
As you may know, the Inflation Reduction Act (IRA) has resulted in significant changes to Part D including:
- Elimination of the Coverage Gap or “donut hole”
- A new $2,000 out-of-pocket spending cap
- A shift in cost sharing responsibility in the catastrophic coverage phase
- A new cost sharing smoothing option
This communication serves as notice of termination without cause of your existing TPME marketing services agreements with Centene for Medicare products effective Dec. 31, 2024. As noted above, Medicare Advantage product compensation will continue into 2025, with your new contract once executed
Aetna Prescription Drug Payment (PDP) Compensation Update
PDP offering available nationwide
In 2025, we will offer SilverScript Choice PDP as a non-commissionable product in all 50 states and Washington, D.C., and we will continue to pay renewal commissions on all existing commissionable SilverScript PDP business.
SilverScript Choice offers a strong combination of brand and generic drugs with more than 1,400 drugs included on our formulary. Tier 1 drugs are no more than $5 at network pharmacies.